Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 651,000 | 592,100 | 693,200 | 653,000 | 651,600 |
| Cost of Goods | 305,200 | 282,700 | 348,000 | 309,600 | 306,300 |
| Gross Profit | 345,800 | 309,400 | 345,200 | 343,400 | 345,300 |
| Operating Expenses | 273,400 | 276,000 | 464,100 | 278,700 | 268,500 |
| Operating Income | 72,600 | 34,100 | -118,900 | 65,300 | 77,100 |
| Interest Expense | 12,100 | 12,300 | 12,100 | 12,300 | 12,600 |
| Other Income | 481,600 | -711,600 | 1,060,200 | -484,100 | 349,500 |
| Pre-tax Income | 542,100 | -689,800 | 929,200 | -431,100 | 414,000 |
| Income Tax | 170,700 | -162,700 | 209,200 | -89,200 | 96,200 |
| Net Income Continuous | 371,400 | -527,100 | 720,000 | -341,900 | 317,800 |
| Net Income | $371,400 | $-527,100 | $720,000 | $-341,900 | $317,800 |
| EPS Basic Total Ops | 13.89 | -19.55 | 26.61 | -12.70 | 11.67 |
| EPS Basic Continuous Ops | 13.89 | -19.55 | 26.61 | -12.70 | 11.67 |
| EPS Diluted Total Ops | 13.85 | -19.55 | 26.59 | -12.70 | 11.67 |
| EPS Diluted Continuous Ops | 13.85 | -19.55 | 26.59 | -12.70 | 11.67 |
| EPS Diluted Before Non-Recurring Items | N/A | 1.89 | 2.51 | 2.26 | 2.61 |
| EBITDA(a) | $72,600 | $34,100 | $-118,900 | $65,300 | $77,100 |